Résultats de recherche

Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at: www. Please send your CV and cove

Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. The precision of Eupraxias DiffuSphere™ technology platform has the potential to augment and tran

Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Companys website at:. Prior experience with supporting

Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other

The precision of Eupraxia's DiffuSphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal d

Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at: We are looking for someone who

Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal diseas

Prior experience with supporting later stage regulatory filings including NDA or MAA · Prior exposure to ‘omics analysis, data mining, or real-world data integration. Senior Biopharmaceutical Statistician   Eupraxia is a clinical-stage biotechnology company focused on developing locally delive

Prior experience with supporting later stage regulatory filings including NDA or MAA · Prior exposure to ‘omics analysis, data mining, or real-world data integration. Senior Biopharmaceutical Statistician   Eupraxia is a clinical-stage biotechnology company focused on developing locally delive

Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other